What Sparks Creates For Healthcare Brands
Sparks has spent more than 40 years creating events and experiences for medical and life sciences brands, including congress programs, activations for HCPs and patients, and branded environments. Backed by The Freeman Company, Sparks runs 5,000+ projects a year across 60 countries with 1,100+ experiential experts and a 90% client retention rate. In a regulated market, every experience has to be innovative, relevant, and compliant.
Sparks’ experience with healthcare brands includes:
- • Congress, convention, and trade show exhibits
- • HCP and patient engagement activations
- • Branded environments, briefing centers, and vision centers
- • Content, product-demo, and immersive storytelling production
- • Virtual and hybrid experiences and product galleries
- • Measurement and analytics tied to business value, using Eventscore®
Services for Healthcare Brands
Sparks brings a full experiential capability set to medical and life sciences brands, spanning strategy, creative, production, registration, fabrication, content, sponsorship, technology, and measurement. The nine services below can be engaged together as an end-to-end program or selected individually, depending on what a given moment needs.
Capabilities That Support Healthcare Experiences
Six capabilities support Sparks’ healthcare experiential programs, each one a discipline Sparks has built in-house rather than assembled from outside vendors. Together, they let complex, regulated science reach clinical and patient audiences without slowing approval.
Creative designed to clear medical, legal, and regulatory review without losing impact. This is the capability generalist agencies most often lack. This includes compliant messaging frameworks, MLR and legal review coordination, claims-safe copy, and correct handling of ISI and boxed-warning requirements inside the experience.
Attendee journeys designed for clinical audiences and patient education alike. This includes attendee journey mapping, HCP-focused booth and congress experiences, patient-education environments, and personalization.
Technology that makes complex science tangible and measurable. This includes AR and VR product demos, custom interactives, gaming and challenges, data and lead capture, and digital signage, plus the TechLite turnkey toolkit and virtual event platforms.
Broadcast-grade content and live production for launches and general sessions. This includes product demo visualizations, motion graphics, XR and virtual green-screen sets, live-stream and webcast studios, and at-home speaker kits.
Owned fabrication and global logistics for consistent, high-quality physical builds. Freeman’s infrastructure extends reach without changing who is accountable for the work. This includes custom exhibit fabrication across multiple in-house facilities, rental integration, global sourcing and shipping, and warehousing.
A closed loop from goals to proof of business value. This includes proprietary EventFit®, EventScore®, Earned Engagement Value (EEV), and Earned Event Impression Value (EEIV) frameworks; impression, engagement, and dwell tracking; benchmarking; and post-event reporting.
Measuring Impact for Healthcare Brands
Healthcare buyers measure success in trust, engagement, and business value. Sparks builds measurement in from the first strategy session, so every experience can be tied back to the outcomes it was designed to drive. The table below shows where that impact shows up.
Brand recall and affinity scores that show whether healthcare providers and patients came away trusting the brand, measured against the perception goals set before the program began.
The volume and quality of conversations with healthcare providers on the floor, from booth traffic and product demos through to the qualified connections a commercial team can follow up on.
Impressions, dwell time, and repeat visits captured through cell-based tracking, so the busiest zones and highest-interest moments of the exhibit are clear and repeatable at the next congress.
EventScore®, Sparks’ proprietary methodology, ties activation metrics back to business outcomes, translating experiential spend into results a brand team can defend in budget conversations.
Experiences that clear medical, legal, and regulatory review without slipping the timeline, so compliance is engineered into the build from the start instead of negotiated at the end.
Healthcare Segments Sparks Serves
Recent Healthcare & Pharma Events and Experiences
Every Sparks healthcare & pharma program starts with a business opportunity and ends with measurable impact. In between, the work takes shape in large-format builds, interactive product demos, hands-on labs, immersive LED environments, and broadcast-ready content, each engineered to move an audience from awareness to action. The case studies below tell those stories.
FEATURED WORK
Frequently Asked Questions About Healthcare and Pharma Brands
Sparks covers strategy, creative, content, event production, interactive technology, in-house fabrication, and measurement as one integrated team. That single-team model keeps the brand vision intact from the objective through the build.
Sparks builds medical, legal, and regulatory review into the project timeline rather than treating it as a final gate. Creative is designed to clear review, with claims-safe copy and correct handling of ISI and boxed-warning requirements inside the experience.
Sparks has worked across pharma, medtech, diagnostics, and pharmacy and distribution, including: Gilead Sciences, GoodRx, McKesson, Medtronic, Optimum Nutrition, Stryker, Viatris, and more.
We use SparksIQ™ and its proprietary frameworks, including EventScore® and EventValue™, which includes Earned Engagement Value (EEV) and Earned Event Impression Value (EEIV). We track impressions, engagement, dwell time, and leads, then tie those metrics to business value so the investment is defensible at the CMO level.
Yes. Sparks runs programs across 60 countries with 14 in-house fabrication and logistics locations in 8 countries, backed by The Freeman Company’s global infrastructure.
LATEST INSIGHTS
-
How Patent Expirations, Pricing Pressure and R&D Costs Are Reshaping Biopharma
view article: How Patent Expirations, Pricing Pressure and R&D Costs Are Reshaping Biopharma -
Why Biopharma Must Rethink Supply Chains, Manufacturing and Regulatory Readiness
view article: Why Biopharma Must Rethink Supply Chains, Manufacturing and Regulatory Readiness -
What AI and Advanced Therapies Demand of Biopharma Leaders
view article: What AI and Advanced Therapies Demand of Biopharma Leaders -
How Trust, Talent and Patient Access Shape Biopharma’s Future
view article: How Trust, Talent and Patient Access Shape Biopharma’s Future